| domain | castlebiosciences.com |
| summary | Castle Laboratories offers a suite of diagnostic and prognostic testing solutions, including DecisionDx-Melanoma, DecisionDx-SCC, DecisionDx-UM, TissueCypher, and AdvanceAD-Tx, primarily focused on cutaneous melanoma, cutaneous squamous cell carcinoma, Barrett’s esophagus, and uveal melanoma. These tests utilize gene expression profiling and spatial biology to predict patient outcomes, guide treatment decisions, and provide valuable scientific evidence. The company also offers patient resources, educational materials, and support through forums and FAQs. They have a strong focus on research and development, detailed in their scientific publications and clinical portal. |
| title | Castle Biosciences | Innovative Molecular Prognostic and Diagnostic Tests |
| description | Castle Biosciences' broad portfolio of innovative tests empowers providers and patients with personalized information to better inform care decisions. Castle Biosciences' broad portfolio of innovative tests empowers providers and patients with person |
| keywords | more, patients, risk, melanoma, decisions, esophagus, treatment, make, tests, patient, castle, plan, test, comprehensive, profiling, care, cancer |
| upstreams |
|
| downstreams |
|
| nslookup | A 198.202.211.1 |
| created | 2025-11-06 |
| updated | 2026-02-02 |
| summarized | 2026-02-03 |
|
|